Press Release: ALTUVIIIOlate-breaking data at ISTH demonstrates highly effective bleed protection in children with severe hemophilia A with once-weekly dosing

https://ift.tt/o5kwpME

 

from Sanofi - Aventis Groupe https://ift.tt/hE6Xe1f
via IFTTT